Nationwide Fund Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-30,552
Closed -$1.77M 122
2017
Q3
$1.77M Sell
30,552
-856
-3% -$44.7K 0.01% 1498
2017
Q2
$1.55M Buy
31,408
+9,780
+45% +$450K 0.01% 1547
2017
Q1
$940K Sell
21,628
-237
-1% -$11.3K ﹤0.01% 1788
2016
Q4
$1.07M Buy
21,865
+377
+2% +$17.4K ﹤0.01% 1735
2016
Q3
$1.03M Sell
21,488
-830
-4% -$41K ﹤0.01% 1770
2016
Q2
$1.2M Sell
22,318
-1,167
-5% -$55K 0.01% 1616
2016
Q1
$1.06M Sell
23,485
-533
-2% -$21.6K ﹤0.01% 1684
2015
Q4
$917K Buy
24,018
+998
+4% +$38.2K ﹤0.01% 1775
2015
Q3
$733K Buy
23,020
+13,516
+142% +$471K ﹤0.01% 1888
2015
Q2
$314K Sell
9,504
-1,102
-10% -$39.3K ﹤0.01% 2487
2015
Q1
$437K Sell
10,606
-407
-4% -$16.5K ﹤0.01% 2302
2014
Q4
$449K Sell
11,013
-148
-1% -$5.79K ﹤0.01% 2240
2014
Q3
$409K Buy
11,161
+94
+0.8% +$4.06K ﹤0.01% 2321
2014
Q2
$513K Buy
+11,067
New +$492K ﹤0.01% 2247
2014
Q1
Sell
-11,439
Closed -$437K 3103
2013
Q4
$437K Sell
11,439
-20,616
-64% -$636K ﹤0.01% 2298
2013
Q3
$768K Buy
32,055
+20,658
+181% +$464K ﹤0.01% 1985
2013
Q2
$194K Buy
+11,397
New +$164K ﹤0.01% 2495

Other funds holding ANIK